MA26510A1 - Compositions pharmaceutiques comprenant un sensibilisant a l'insuline et un agent antihyperglycemique pour une methode de traitement du diabete - Google Patents

Compositions pharmaceutiques comprenant un sensibilisant a l'insuline et un agent antihyperglycemique pour une methode de traitement du diabete

Info

Publication number
MA26510A1
MA26510A1 MA25121A MA25121A MA26510A1 MA 26510 A1 MA26510 A1 MA 26510A1 MA 25121 A MA25121 A MA 25121A MA 25121 A MA25121 A MA 25121A MA 26510 A1 MA26510 A1 MA 26510A1
Authority
MA
Morocco
Prior art keywords
pharmaceutical compositions
treating diabetes
insulin sensitizer
antihyperglycemic agent
antihyperglycemic
Prior art date
Application number
MA25121A
Other languages
English (en)
French (fr)
Inventor
Dr Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9712865.6A external-priority patent/GB9712865D0/en
Priority claimed from GBGB9806708.5A external-priority patent/GB9806708D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MA26510A1 publication Critical patent/MA26510A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA25121A 1997-06-18 1998-06-17 Compositions pharmaceutiques comprenant un sensibilisant a l'insuline et un agent antihyperglycemique pour une methode de traitement du diabete MA26510A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9712865.6A GB9712865D0 (en) 1997-06-18 1997-06-18 Novel method of treatment
GBGB9806708.5A GB9806708D0 (en) 1998-03-27 1998-03-27 Novel method

Publications (1)

Publication Number Publication Date
MA26510A1 true MA26510A1 (fr) 2004-12-20

Family

ID=26311746

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25121A MA26510A1 (fr) 1997-06-18 1998-06-17 Compositions pharmaceutiques comprenant un sensibilisant a l'insuline et un agent antihyperglycemique pour une methode de traitement du diabete

Country Status (24)

Country Link
EP (1) EP0975343A1 (ko)
JP (1) JP2001523271A (ko)
KR (1) KR20010013845A (ko)
CN (1) CN1274282A (ko)
AP (1) AP9901720A0 (ko)
AR (2) AR014881A1 (ko)
AU (1) AU8799998A (ko)
BG (1) BG103966A (ko)
BR (1) BR9810186A (ko)
CA (1) CA2294134A1 (ko)
CO (1) CO4940453A1 (ko)
DZ (1) DZ2519A1 (ko)
EA (1) EA200000040A1 (ko)
IL (1) IL133138A0 (ko)
MA (1) MA26510A1 (ko)
NO (1) NO996270L (ko)
NZ (1) NZ501345A (ko)
OA (1) OA11631A (ko)
PE (1) PE89199A1 (ko)
PL (1) PL337577A1 (ko)
SK (1) SK179499A3 (ko)
TR (1) TR199903072T2 (ko)
UY (1) UY25051A1 (ko)
WO (1) WO1998057635A1 (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0009934A (pt) 1999-04-23 2002-06-04 Smithkline Beecham Plc Produto farmacêutico
CN100384430C (zh) 2001-04-04 2008-04-30 奥索-麦克尼尔药品公司 含有葡萄糖重吸收抑制剂和维生素a类-x受体调节剂的联合治疗
CA2442917C (en) 2001-04-04 2011-02-01 Ortho-Mcneil Pharmaceutical, Inc. Combination therapy comprising glucose reabsorption inhibitors and ppar modulators
FR2832930A1 (fr) * 2001-12-03 2003-06-06 Lipha Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
JP2004067575A (ja) * 2002-08-06 2004-03-04 Yaizu Suisankagaku Industry Co Ltd 糖尿病治療薬効果促進剤
CN101121004B (zh) * 2006-08-08 2010-07-21 鲁南制药集团股份有限公司 含有胰岛素增敏剂和米格列醇的药物组合物
CN101584688B (zh) * 2008-05-24 2010-11-10 鲁南制药集团股份有限公司 一种治疗糖尿病及其并发症的药物组合物
CN101584705B (zh) * 2008-05-24 2010-10-27 鲁南制药集团股份有限公司 一种治疗糖尿病及其并发症的药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5900435A (en) * 1991-08-26 1999-05-04 Pharmacia & Upjohn Company Composition, food product and uses of 3-guanidinopropionic acid
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes

Also Published As

Publication number Publication date
AR013352A1 (es) 2000-12-27
WO1998057635A1 (en) 1998-12-23
AP9901720A0 (en) 1999-12-31
UY25051A1 (es) 2000-09-29
JP2001523271A (ja) 2001-11-20
KR20010013845A (ko) 2001-02-26
AU8799998A (en) 1999-01-04
TR199903072T2 (xx) 2000-07-21
OA11631A (en) 2004-11-22
AR014881A1 (es) 2001-04-11
PE89199A1 (es) 1999-10-23
IL133138A0 (en) 2001-03-19
BG103966A (bg) 2000-07-31
CO4940453A1 (es) 2000-07-24
PL337577A1 (en) 2000-08-28
EA200000040A1 (ru) 2000-08-28
SK179499A3 (en) 2000-11-07
NO996270D0 (no) 1999-12-17
DZ2519A1 (fr) 2003-02-01
NO996270L (no) 1999-12-17
NZ501345A (en) 2001-10-26
CN1274282A (zh) 2000-11-22
BR9810186A (pt) 2000-08-08
EP0975343A1 (en) 2000-02-02
CA2294134A1 (en) 1998-12-23

Similar Documents

Publication Publication Date Title
MA26512A1 (fr) Composition pharmaceutique pour une methode de traitement du diabete sucre.
NO993646D0 (no) Tiazol benzensulfonamider som <beta>3-agonister for behandling av diabetes og fedme
NL300432I2 (en) Pharmaceutical composition comprising pioglitazoneand glimepiride for use in treatment of diabetes.
MA26510A1 (fr) Compositions pharmaceutiques comprenant un sensibilisant a l'insuline et un agent antihyperglycemique pour une methode de traitement du diabete
MX9802130A (es) Agonistas adrenergicos beta3 selectivos.
FR2732223B1 (fr) Composition pharmaceutique pour administration transdermique
DZ2539A1 (fr) Compositions pharmaceutiques pour le traitement dela résistance à l'insuline.
BE881680A (fr) Composition pharmaceutique a base d'acylcarnitine pour le traitement d'un metabolisme cerebral altere et methode utilisee a cet effet
NO973489D0 (no) Stabilisert gassemulsjon inneholdende fosfolipid til kontrastforbedring ved ultralydundersökelser
TNSN96072A1 (fr) N-(indole -2-carbonyl)-glycinamides substitues, procede pour leur preparation et compositions les contenant
FI972287A (fi) Uudenlaisia polysubstituoituja DTPA-johdoksia ja niiden metallikomplekseja, kyseisiä komplekseja sisältäviä farmaseuttisia aineita, niiden käyttö diagnosoinnissa ja terapiassa sekä menetelmiä kyseisten kompleksinmuodostajien ja kompleksien valmistamiseksi ja menetelmiä kyseisten.
TNSN96104A1 (fr) Trihydrate de metahensulfonate de (1s,2s)-1-(4-hydroxyphenyl) -2-(4-hydroxy-4-phenylpiperidine-1-yl)-1-propanol et composition pharmaceutique le contenant
FR2787789B1 (fr) Benzopyranes et benzoxepines utilisables dans le traitement de dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procedes de preparations
DE59609926D1 (de) Stabilisierte schilddrüsenhormonhaltige arzneimittel
DE69629413D1 (de) Flüssigkristallverbindung und diese enthaltende Flüssigkristall-Zusammensetzung
MA26608A1 (fr) Procede de preparation d'une composition pharmaceutique destinee au traitement de l'insuffisance cardiaque.
DZ2521A1 (fr) Compositions pharmaceutiques comprenant de la 5-Ä4-Ä2-(méthyl-n-(2-pyridyl)amino)éthoxyÜbenzylÜ-thiazolidine-2,4-dione et de l'insuline pour une méthode de traitement.
FR2716075B1 (fr) Procédé pour renforcer l'efficacité d'un produit chimique agricole, renforçateur et composition de renforçateur utilisés dans ce procédé et composition chimique agricole comprenant ce renforçateur.
BR0011928A (pt) Composto, composição farmacêutica, uso de, um composto e métodos para o tratamento de complicações diabéticas, para o tratamento ou a prevenção do desenvolvimento de condições de doença associadas com velocidade de condução neuronial prejudicada e de neuropatia diabética
MA24571A1 (fr) Compositions comprenant un sensibilisant a l'insuline et un secretagogue d'insuline pour une methode de traitement
FR2559668B1 (fr) Compositions pharmaceutiques pour le traitement du diabete et de maladies et defauts de fonctionnement du foie
MA26522A1 (fr) Composition pharmaceutique pour le traitement du diabete sucre et d'etats associes.
HUP0003626A2 (hu) Gyógyszerkészítmény diabetes kezelésére dioxo-tiazolidinnel, inzulin secretagogummal és alfa-glükozidáz inhibitorral
DE69630156D1 (de) Naphtholverbindung sowie Flüssigkristallzusammensetzung und Flüssigkristallelement, die diese Verbindung enthalten
DE69704240D1 (de) Flüssigentwicklerzusammensetzung und Verfahren zu deren Herstellung